학술논문
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients with Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial
Document Type
Article
Author
Krop, I.E.; Masuda, N.; Mukohara, T.; Takahashi, S.; Nakayama, T.; Inoue, K.; Iwata, H.; Yamamoto, Y.; Alvarez, R.H.; Toyama, T.; Takahashi, M.; Osaki, A.; Saji, S.; Sagara, Y.; O'Shaughnessy, J.; Ohwada, S.; Koyama, K.; Inoue, T.; Li, L.; Patel, P.; Mostillo, J.; Tanaka, Y.; Sternberg, D.W.; Sellami, D.; Yonemori, K.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 December 2023, 41(36):5550-5560)
Subject
Language
English
ISSN
15277755
0732183X
0732183X